Human Apolipoprotein H Antibody (IgG) ELISA Kit (Sandwich ELISA)
Catalog Number: LS-F67372-1
1 plate / $591.00
Reactivity: Human
Detection Method Colorimetric
Format: 96-Well Strip Plate
Western blot of C1QTNF9 antibody.
C1QTNF9 Antibody (aa20-333)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunocytochemistry, Immunohistochemistry (general), Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$326.00each
Catalog Number: LS-C373857-100
Catalog Number: LS-C373857
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- C1QTNF9 antibody LS-C373857 is an unconjugated rabbit polyclonal antibody to human C1QTNF9 (aa20-333). Validated for WB. Cited in 2 publications.
- Application
- ELISA, ICC, IHC, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- AQL1 | C1QTNF9 | C1QTNF9A | CTRP9
- Recommended Dilution: ELISA
- 1:100-1:5000
- Recommended Dilution: IF/ICC
- 1:50-500
- Recommended Dilution: WB
- 1:50 - 1:400
- UniProt Number
- P0C862
- NCBI GenBank
- NM_178540 | NP_848635.2
- SwissProt
- P0C862
Target
- Target
- Human C1QTNF9
- Antigen Species
- Human
- Epitope
- The antibody is a rabbit polyclonal antibody raised against C1QTNF9.
- Gene Name
- C1QTNF9
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- Recombinant C1QTNF9 (Gln20-Pro333)
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- 0.01 M PBS, pH 7.4, 0.05% ProClin™ 300, 50% Glycerol
- Concentration
- 0.5 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
- Recommended Storage Buffer
- 0.01 M PBS
Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Zhao D, Feng P, Sun Y, Qin Z, Zhang Z, Tan Y, Gao E, Lau WB, Ma X, Yang J, Yu S, Xu X, Yi D, Yi W. Cell death & disease. 2018 June;9:723.
PubMed: 29925877 · PMC: PMC6010444
CTRP9 overexpression attenuates palmitic acid-induced inflammation, apoptosis and impaired migration in HTR8/SVneo cells through AMPK/SREBP1c signaling. Li Li, Zhongyi Gu, Junjie Zhang. Experimental and therapeutic medicine. 2022 July;24:459.
PubMed: 35747146 · PMC: PMC9204553
